- 询价
- MCE
- HY-L009M
- 2026年03月18日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
【化合物数量】271
- 供应商：
广州市左克生物
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Purification of Myosin Light Chain Kinase
inhibitor* - 8ml of 1mg/ml stock solution pH 7.0 3.Buffer B DE 52 Wash 10 mM MOPS- 20ml of 2M stock solution 4 liters 1 mM EDTA- 20ml of 0.2M stock solution 1 mM DTT* - 4ml of 1M stock solution 0.1 mM PMSF* - 7ml of 10mg/ml stock solution pH
ERBB4 Mutation Analysis: Emerging Molecular Target for Melanoma Treatment
to small-molecule inhibition with the dual-tyrosine kinase inhibitor lapatinib, and has recently also been implied in oncogenic glutamatergic signaling in melanoma. Mutations involving the ERBB4 gene act as “gain-of-function” mutations and predominantly
Analysis of Proteins using Small Format 2D Gel Electrophoresis
gel. Further information is also available on the preparation of bacterial proteins for 2DE. Protein analysis on small format 2D gels The analytical system presented below was developed using the Mini Protean II
技术资料暂无技术资料 索取技术资料
